Cargando…

Immunotherapy: TIMING OF DONOR SELECTION ON CD45RA-MEMORY T CELLS AS ADOPTIVE CELL THERAPY FOR COVID-19

Detalles Bibliográficos
Autores principales: Al-Akioui, K., Díaz-Almirón, M., Vicario, J.L., Balas, A., Hidalgo, M. Moreno, Soria, B., Perez-Martinez, A., Ferreras, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society for Cell & Gene Therapy. Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035760/
http://dx.doi.org/10.1016/S1465-3249(22)00307-3
_version_ 1784693368574443520
author Al-Akioui, K.
Díaz-Almirón, M.
Vicario, J.L.
Balas, A.
Hidalgo, M. Moreno
Soria, B.
Perez-Martinez, A.
Ferreras, C.
author_facet Al-Akioui, K.
Díaz-Almirón, M.
Vicario, J.L.
Balas, A.
Hidalgo, M. Moreno
Soria, B.
Perez-Martinez, A.
Ferreras, C.
author_sort Al-Akioui, K.
collection PubMed
description
format Online
Article
Text
id pubmed-9035760
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher International Society for Cell & Gene Therapy. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-90357602022-04-25 Immunotherapy: TIMING OF DONOR SELECTION ON CD45RA-MEMORY T CELLS AS ADOPTIVE CELL THERAPY FOR COVID-19 Al-Akioui, K. Díaz-Almirón, M. Vicario, J.L. Balas, A. Hidalgo, M. Moreno Soria, B. Perez-Martinez, A. Ferreras, C. Cytotherapy POSTER ABSTRACTS: Immunotherapy International Society for Cell & Gene Therapy. Published by Elsevier Inc. 2022-05 2022-04-25 /pmc/articles/PMC9035760/ http://dx.doi.org/10.1016/S1465-3249(22)00307-3 Text en Copyright © 2022 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle POSTER ABSTRACTS: Immunotherapy
Al-Akioui, K.
Díaz-Almirón, M.
Vicario, J.L.
Balas, A.
Hidalgo, M. Moreno
Soria, B.
Perez-Martinez, A.
Ferreras, C.
Immunotherapy: TIMING OF DONOR SELECTION ON CD45RA-MEMORY T CELLS AS ADOPTIVE CELL THERAPY FOR COVID-19
title Immunotherapy: TIMING OF DONOR SELECTION ON CD45RA-MEMORY T CELLS AS ADOPTIVE CELL THERAPY FOR COVID-19
title_full Immunotherapy: TIMING OF DONOR SELECTION ON CD45RA-MEMORY T CELLS AS ADOPTIVE CELL THERAPY FOR COVID-19
title_fullStr Immunotherapy: TIMING OF DONOR SELECTION ON CD45RA-MEMORY T CELLS AS ADOPTIVE CELL THERAPY FOR COVID-19
title_full_unstemmed Immunotherapy: TIMING OF DONOR SELECTION ON CD45RA-MEMORY T CELLS AS ADOPTIVE CELL THERAPY FOR COVID-19
title_short Immunotherapy: TIMING OF DONOR SELECTION ON CD45RA-MEMORY T CELLS AS ADOPTIVE CELL THERAPY FOR COVID-19
title_sort immunotherapy: timing of donor selection on cd45ra-memory t cells as adoptive cell therapy for covid-19
topic POSTER ABSTRACTS: Immunotherapy
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035760/
http://dx.doi.org/10.1016/S1465-3249(22)00307-3
work_keys_str_mv AT alakiouik immunotherapytimingofdonorselectiononcd45ramemorytcellsasadoptivecelltherapyforcovid19
AT diazalmironm immunotherapytimingofdonorselectiononcd45ramemorytcellsasadoptivecelltherapyforcovid19
AT vicariojl immunotherapytimingofdonorselectiononcd45ramemorytcellsasadoptivecelltherapyforcovid19
AT balasa immunotherapytimingofdonorselectiononcd45ramemorytcellsasadoptivecelltherapyforcovid19
AT hidalgommoreno immunotherapytimingofdonorselectiononcd45ramemorytcellsasadoptivecelltherapyforcovid19
AT soriab immunotherapytimingofdonorselectiononcd45ramemorytcellsasadoptivecelltherapyforcovid19
AT perezmartineza immunotherapytimingofdonorselectiononcd45ramemorytcellsasadoptivecelltherapyforcovid19
AT ferrerasc immunotherapytimingofdonorselectiononcd45ramemorytcellsasadoptivecelltherapyforcovid19